Literature DB >> 29285495

Antibody-drug conjugate targeting protein tyrosine kinase 7, a receptor tyrosine kinase-like molecule involved in WNT and vascular endothelial growth factor signaling: effects on cancer stem cells, tumor microenvironment and whole-body homeostasis.

Masaru Katoh1.   

Abstract

Entities:  

Year:  2017        PMID： 29285495      PMCID： PMC5733325          DOI： 10.21037/atm.2017.09.11

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  36 in total

1.  Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma.

Authors:  Monica Bartucci; Mohamed S Hussein; Eric Huselid; Kathleen Flaherty; Michele Patrizii; Saurabh V Laddha; Cindy Kui; Rachel A Bigos; John A Gilleran; Mervat M S El Ansary; Mona A M Awad; S David Kimball; David J Augeri; Hatem E Sabaawy
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

Review 2.  Coming-of-Age of Antibodies in Cancer Therapeutics.

Authors:  B Vijayalakshmi Ayyar; Sushrut Arora; Richard O'Kennedy
Journal:  Trends Pharmacol Sci       Date:  2016-10-10       Impact factor: 14.819

3.  Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors.

Authors:  Shanta M Messerli; Mariah M Hoffman; Etienne Z Gnimpieba; Ratan D Bhardwaj
Journal:  Mol Cancer Res       Date:  2017-04-25       Impact factor: 5.852

Review 4.  Therapeutics Targeting FGF Signaling Network in Human Diseases.

Authors:  Masaru Katoh
Journal:  Trends Pharmacol Sci       Date:  2016-10-27       Impact factor: 14.819

5.  Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.

Authors:  Rosemarie C D'Angelo; Maria Ouzounova; April Davis; Daejin Choi; Stevie M Tchuenkam; Gwangil Kim; Tahra Luther; Ahmed A Quraishi; Yasin Senbabaoglu; Sarah J Conley; Shawn G Clouthier; Khaled A Hassan; Max S Wicha; Hasan Korkaya
Journal:  Mol Cancer Ther       Date:  2015-02-11       Impact factor: 6.261

6.  PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.

Authors:  Silvia Gärtner; Angela Gunesch; Tatiana Knyazeva; Petra Wolf; Bernhard Högel; Wolfgang Eiermann; Axel Ullrich; Pjotr Knyazev; Beyhan Ataseven
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

7.  PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.

Authors:  Xiuyun Tian; Liang Yan; Donghai Zhang; Xiaoya Guan; Bin Dong; Min Zhao; Chunyi Hao
Journal:  Oncol Rep       Date:  2016-07-28       Impact factor: 3.906

8.  Molecular genetics and targeted therapy of WNT-related human diseases (Review).

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Mol Med       Date:  2017-07-19       Impact factor: 4.101

9.  FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.

Authors:  M Asad; M K Wong; T Z Tan; M Choolani; J Low; S Mori; D Virshup; J P Thiery; R Y-J Huang
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

10.  The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway.

Authors:  Sébastien Martinez; Pierluigi Scerbo; Marilyn Giordano; Avais M Daulat; Anne-Catherine Lhoumeau; Virginie Thomé; Laurent Kodjabachian; Jean-Paul Borg
Journal:  J Biol Chem       Date:  2015-10-23       Impact factor: 5.157
View more
  7 in total

1.  The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

Authors:  Michael D Paul; Kalina Hristova
Journal:  Chem Rev       Date:  2018-12-27       Impact factor: 60.622

2.  Effectiveness of Antibody-Drug Conjugate (ADC): Results of In Vitro and In Vivo Studies.

Authors:  Xiuhua Kang; Li Zhou; Ya-Mei Jian; Shao-An Lan; Fei Xu
Journal:  Med Sci Monit       Date:  2018-03-08

3.  Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.

Authors:  Yiran Tao; Ruixue Wang; Qinhuai Lai; Mengdan Wu; Yuxi Wang; Xiaohua Jiang; Lishi Zeng; Shijie Zhou; Zhongping Li; Tinghan Yang; Yuqin Yao; Yangping Wu; Lin Yu; Yuyin Fu; Weirong Lai; Yujia Peng; Ying Lu; Zhixiong Zhang; Cuiyu Guo; Guangbing Zhang; Lantu Gou; Jinliang Yang
Journal:  Mol Oncol       Date:  2019-07-22       Impact factor: 6.603

Review 4.  CAR T Cell Therapy for Pediatric Brain Tumors.

Authors:  John D Patterson; Jeffrey C Henson; Rebecca O Breese; Kevin J Bielamowicz; Analiz Rodriguez
Journal:  Front Oncol       Date:  2020-08-12       Impact factor: 6.244

Review 5.  Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer.

Authors:  Sara El-Sahli; Lisheng Wang
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 6.  New Era of Immunotherapy in Pediatric Brain Tumors: Chimeric Antigen Receptor T-Cell Therapy.

Authors:  Wan-Tai Wu; Wen-Ying Lin; Yi-Wei Chen; Chun-Fu Lin; Hsin-Hui Wang; Szu-Hsien Wu; Yi-Yen Lee
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

Review 7.  Fate decisions of breast cancer stem cells in cancer progression.

Authors:  Hui Xu; Fengxia Zhang; Xiaokang Gao; Qiwang Zhou; Linhai Zhu
Journal:  Front Oncol       Date:  2022-08-15       Impact factor: 5.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.